TB-500 provides systemic healing and flexibility support
By completing your purchase, you acknowledge that BPC-157 (Body Protection Compound-157) is an investigational material not approved for general medical or therapeutic use by any regulatory authority
Many report noticeable changes within 2-4 weeks, depending on individual health conditions, lifestyle, and recovery demands
Although some patients develop a mild rash to allopurinol that remains mild over time, or respond to antihistamines, continuing the allopurinol despite a rash is not advised, since the rash can worsen unpredictably
There is a striking and concerning lack of human evidence
Bismah Irfan, MD, sees the same handful of reconstitution errors repeatedly in her IVitality MD practice